BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34210720)

  • 1. Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol.
    Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S
    BMJ Open; 2021 Jul; 11(7):e043921. PubMed ID: 34210720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn's disease.
    Gu B; Venkatesh K; Williams AJ; Ng W; Corte C; Gholamrezaei A; Ghaly S; Xuan W; Paramsothy S; Connor S
    World J Gastroenterol; 2022 Jun; 28(23):2597-2608. PubMed ID: 35949350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).
    Papamichael K; Jairath V; Zou G; Cohen B; Ritter T; Sands B; Siegel C; Valentine J; Smith M; Vande Casteele N; Dubinsky M; Cheifetz A
    BMJ Open; 2022 Apr; 12(4):e057656. PubMed ID: 35365535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease.
    Davidov Y; Ungar B; Bar-Yoseph H; Carter D; Haj-Natour O; Yavzori M; Chowers Y; Eliakim R; Ben-Horin S; Kopylov U
    J Crohns Colitis; 2017 May; 11(5):549-555. PubMed ID: 28453755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Zhu M; Xu X; Feng Q; Cui Z; Wang T; Yan Y; Ran Z
    Dig Dis Sci; 2021 May; 66(5):1658-1668. PubMed ID: 32524415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining and predicting deep remission in patients with perianal fistulizing Crohn's disease on anti-tumor necrosis factor therapy.
    Papamichael K; Cheifetz AS
    World J Gastroenterol; 2017 Sep; 23(34):6197-6200. PubMed ID: 28974885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn's disease: a retrospective cohort study.
    Zhu P; Sun JF; Gu YF; Chen HJ; Xu MM; Li YR; Yang BL
    BMC Gastroenterol; 2022 Jan; 22(1):15. PubMed ID: 35012467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.
    Yarur AJ; Kanagala V; Stein DJ; Czul F; Quintero MA; Agrawal D; Patel A; Best K; Fox C; Idstein K; Abreu MT
    Aliment Pharmacol Ther; 2017 Apr; 45(7):933-940. PubMed ID: 28211593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
    Schwartz DA; White CM; Wise PE; Herline AJ
    Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn's Perianal Fistulas.
    De Gregorio M; Lee T; Krishnaprasad K; Amos G; An YK; Bastian-Jordan M; Begun J; Borok N; Brown DJM; Cheung W; Connor SJ; Gerstenmaier J; Gilbert LE; Gilmore R; Gu B; Kutaiba N; Lee A; Mahy G; Srinivasan A; Thin L; Thompson AJ; Welman CJ; Yong EXZ; De Cruz P; van Langenberg D; Sparrow MP; Ding NS
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1306-1314. PubMed ID: 34389484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab maintenance therapy for fistulizing Crohn's disease.
    Sands BE; Anderson FH; Bernstein CN; Chey WY; Feagan BG; Fedorak RN; Kamm MA; Korzenik JR; Lashner BA; Onken JE; Rachmilewitz D; Rutgeerts P; Wild G; Wolf DC; Marsters PA; Travers SB; Blank MA; van Deventer SJ
    N Engl J Med; 2004 Feb; 350(9):876-85. PubMed ID: 14985485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
    Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
    Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
    [No Abstract]   [Full Text] [Related]  

  • 14. Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn's disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA.
    Minar PP; Colman RJ; Zhang N; Mizuno T; Vinks AA
    BMJ Open; 2024 Mar; 14(3):e077193. PubMed ID: 38531570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study.
    Alessandroni L; Kohn A; Cosintino R; Marrollo M; Papi C; Monterubbianesi R; Tersigni R
    Tech Coloproctol; 2011 Dec; 15(4):407-12. PubMed ID: 22011835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.
    Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Kwiecień J; Korczowski B; Maślana J
    Adv Clin Exp Med; 2016; 25(3):523-30. PubMed ID: 27629741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
    Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Neutrophil Extracellular Traps with Fistula Healing in Patients with Complex Perianal Fistulizing Crohn's Disease.
    Cao D; Qian K; Zhao Y; Hong J; Chen H; Wang X; Yang N; Zhang C; Cao J; Jia K; Wu G; Zhu M; Shen J; Zhang Y; Cui Z; Wang Z
    J Crohns Colitis; 2023 Apr; 17(4):580-592. PubMed ID: 36322703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.
    Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR
    Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.